13F-HR filed by NOVO HOLDINGS A/S
NOVO HOLDINGS A/S filed this 13F-HR for the quarter ended 2015-06-30, filed 2015-08-14, with 19 holding rows worth $1,390,515,000.
- Accession
- 0000950123-15-009039
- Filer
- CIK 1388325
- Filed
- 2015-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2015
A holdings report, 19 entries on the cover page, a total value of $1,390,515,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,390,516,000 with VALUE read as thousands by filing date, 13F file number 028-16231. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VTI | 922908769 | COM | 2,979,100 | $318,823,000 | thousands by filing date | |
| OPHTHOTECH CORP | 683745103 | COM | 4,910,487 | $255,640,000 | thousands by filing date | |
| INOGEN INC | 45780L104 | COM | 3,549,320 | $158,300,000 | thousands by filing date | |
| WRIGHT MED GROUP INC | 98235T115 | RIGHT 03/01/2019 | 4,720,065 | $123,949,000 | thousands by filing date | principal |
| Vanguard FTSE Europe ETF | 922042874 | SHS | 2,101,000 | $113,412,000 | thousands by filing date | |
| ALDER BIOPHARMACEUTICALS INC | 014339105 | COM | 1,951,183 | $103,354,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 1,525,704 | $82,007,000 | thousands by filing date | |
| FLEXION THERAPEUTICS INC | 33938J106 | COM | 2,133,131 | $46,694,000 | thousands by filing date | |
| TOBIRA THERAPEUTICS INC COM | 88883P101 | COM | 2,696,405 | $46,513,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 1,761,567 | $32,290,000 | thousands by filing date | |
| COLUCID PHARMACEUTICALS INC | 19716T101 | COM | 3,056,563 | $27,203,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 875,025 | $20,117,000 | thousands by filing date | |
| TOKAI PHARMACEUTICALS INC COM | 88907J107 | Stock | 1,238,252 | $16,469,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 1,516,387 | $15,604,000 | thousands by filing date | |
| HTG MOLECULAR DIAGNOSTICS IN | 40434H104 | COM | 1,280,185 | $14,274,000 | thousands by filing date | |
| INVUITY INC | 46187J106 | COM | 740,616 | $10,457,000 | thousands by filing date | |
| GLAUKOS CORP COM | 377322102 | Stock | 75,000 | $2,174,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 100,000 | $1,765,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 127,563 | $1,471,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-15-009039 | this filing | 2015-08-14 | acceptance time not in the bulk data set |